Aspirin inhibits the carcinogenesis of esophageal squamous cell carcinoma and enhances its responses to cisplatin

被引：0
|
作者：
Zou, Zhigeng
Fan, Hongjun
Yu, Xiying
Zhang, Shuming
Guo, Liping
Jiang, Wei
Lu, Shih-Hsin
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1262
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1262
引用
收藏
页数：2
相关论文
共 50 条
  • [41] MiR-630 inhibits invasion and metastasis in esophageal squamous cell carcinoma
    Jin, Li
    Yi, Jun
    Gao, Yanping
    Han, Siqi
    He, Zhenyue
    Chen, Longbang
    Song, Haizhu
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2016, 48 (09) : 810 - 819
  • [42] PFKL promotes cell viability and glycolysis and inhibits cisplatin chemosensitivity of laryngeal squamous cell carcinoma
    Wang, Peng
    Ye, Yixian
    Chen, Zhaoyue
    Li, Ruilong
    Hou, Guanghui
    Liu, Zheng
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 730
  • [43] Neoadjuvant chemotherapy with S-1 plus cisplatin for esophageal squamous cell carcinoma
    Takahashi, Takamasa
    Kaneoka, Yuji
    Maeda, Atsuyuki
    Takayama, Yuichi
    Seita, Kazuaki
    UPDATES IN SURGERY, 2022, 74 (02) : 675 - 683
  • [44] Dihydroartemisinin Sensitizes Esophageal Squamous Cell Carcinoma to Cisplatin by Inhibiting Sonic Hedgehog Signaling
    Cui, Wei
    Fang, Tingting
    Duan, Zhaoheng
    Xiang, Dongfang
    Wang, Yanxia
    Zhang, Mengsi
    Zhai, Fangzheng
    Cui, Xiang
    Yang, Lang
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [45] Neoadjuvant Chemoradiotherapy with Cisplatin Plus Fluorouracil for Borderline Resectable Esophageal Squamous Cell Carcinoma
    Suzuki, Takeshi
    Okamura, Akihiko
    Watanabe, Masayuki
    Mine, Shinji
    Imamura, Yu
    Asari, Takao
    Osumi, Hiroki
    Nakayama, Izuma
    Ichimura, Takashi
    Ogura, Mariko
    Ooki, Akira
    Takahari, Daisuke
    Yamaguchi, Kensei
    Chin, Keisho
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (05) : 1510 - 1517
  • [46] Neoadjuvant chemotherapy with S-1 plus cisplatin for esophageal squamous cell carcinoma
    Takamasa Takahashi
    Yuji Kaneoka
    Atsuyuki Maeda
    Yuichi Takayama
    Kazuaki Seita
    Updates in Surgery, 2022, 74 : 675 - 683
  • [47] Integrin α5 promotes migration and cisplatin resistance in esophageal squamous cell carcinoma cells
    Hou, Sicong
    Jin, Weiguo
    Xiao, Weiming
    Deng, Bin
    Wu, Dacheng
    Zhi, Jiehua
    Wu, Keyan
    Cao, Xiaowei
    Chen, Shuai
    Ding, Yanbing
    Shi, Hongcan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2019, 9 (12): : 2774 - 2788
  • [48] A Novel Circular RNA enhancing Resistance to Cisplatin in Esophageal Squamous Cell Carcinoma.
    Yamada, Moyuru
    Tanaka, Koji
    Yamashita, Kotaro
    Saito, Takuro
    Yamamoto, Kazuyoshi
    Makino, Tomoki
    Takahashi, Tsuyoshi
    Kurokawa, Yukinori
    Yamasaki, Makoto
    Nakajima, Kiyokazu
    Eguchi, Hidetoshi
    Doki, Yuichiro
    CANCER SCIENCE, 2021, 112 : 645 - 645
  • [49] Cyclin D1 overexpression in esophageal dysplasia: a possible biomarker for carcinogenesis of esophageal squamous cell carcinoma
    Shamma, A
    Doki, Y
    Shiozaki, H
    Tsujinaka, T
    Yamamoto, M
    Inoue, M
    Nano, M
    Monden, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 16 (02) : 261 - 266
  • [50] Anlotinib combined with paclitaxel and cisplatin as neoadjuvant treatment for esophageal squamous cell carcinoma (ESCC).
    Jiang, Gongqian
    Wang, Guolei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 409 - 409
12345